Mulok, Hadia M.

HRN: 23-65-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
AMPICILLIN 500MG (VIAL)
09/05/2023
09/11/2023
IV
180
Q6
Uti
Waiting Final Action 
09/05/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/05/2023
09/11/2023
PO
3ml
TID
Amoebiasis
Waiting Final Action 
09/08/2023
CEFTRIAXONE 1G (VIAL)
09/08/2023
09/14/2023
IV
550mg
OD
PCAP C
Waiting Final Action 
09/11/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/11/2023
09/15/2023
PO
1.4ml
Od
Pcap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: